Amneal Pharmaceuticals, Inc. (AMRX) Ownership

$7.75

$0.21 (-2.64%)
Last update: 04:00 PM EST
Day's range
$7.72
Day's range
$7.9

Amneal Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 05/09/2025 15.76 M $132.09 M   6.20% 5.07%
BLACKROCK, INC. 05/02/2025 12.59 M $105.49 M   0.00% 4.05%
TPG GP A, LLC 05/15/2025 12.33 M $103.32 M   0.00% 3.96%
RUBRIC CAPITAL MANAGEMENT LP 05/14/2025 10.74 M $89.97 M   0.13% 3.45%
CITADEL ADVISORS LLC 05/15/2025 7.49 M $62.78 M   -16.58% 2.41%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 5.10 M $42.76 M   2.23% 1.64%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.83 M $32.06 M   0.32% 1.23%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2025 3.81 M $31.92 M   3.90% 1.22%
NEUBERGER BERMAN GROUP LLC 05/13/2025 3.74 M $31.40 M   -0.74% 1.20%
STATE STREET CORP 05/15/2025 3.69 M $30.93 M   -0.21% 1.19%
BLACKBARN CAPITAL PARTNERS LP 05/14/2025 2.88 M $24.15 M   1.11% 0.93%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 2.60 M $21.76 M   51.26% 0.84%
05/12/2025 2.34 M $19.58 M   100.00% 0.75%
INVESCO LTD. 05/12/2025 2.27 M $19.05 M   19.16% 0.73%
MILLENNIUM MANAGEMENT LLC 05/15/2025 2.09 M $17.49 M   57.59% 0.67%
UBS GROUP AG 05/13/2025 1.81 M $15.19 M   8.82% 0.58%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2025 1.79 M $15.03 M   16.38% 0.58%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.77 M $14.81 M   14.78% 0.57%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 1.77 M $14.80 M   36.05% 0.57%
NORTHERN TRUST CORP 05/13/2025 1.71 M $14.32 M   -3.86% 0.55%
AMERIPRISE FINANCIAL INC 05/14/2025 1.66 M $13.94 M   8.06% 0.53%
MORGAN STANLEY 05/15/2025 1.62 M $13.58 M   8.96% 0.52%
WOODLINE PARTNERS LP 05/15/2025 1.50 M $12.60 M   165.24% 0.48%
HENNESSY ADVISORS INC 04/16/2025 1.50 M $12.56 M   -10.25% 0.48%
PRUDENTIAL FINANCIAL INC 05/13/2025 1.38 M $11.54 M   16.29% 0.44%
PHOCAS FINANCIAL CORP. 05/09/2025 1.26 M $10.55 M   -5.34% 0.40%
JPMORGAN CHASE & CO 05/12/2025 1.09 M $9.15 M   -10.15% 0.35%
GOLDMAN SACHS GROUP INC 05/16/2025 937.19 K $7.85 M   -3.75% 0.30%
ASSENAGON ASSET MANAGEMENT S.A. 04/15/2025 819.74 K $6.87 M   7.79% 0.26%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 745.48 K $6.25 M   121.34% 0.24%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 719.08 K $6.03 M   317.31% 0.23%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 684.12 K $5.73 M   100.00% 0.22%
TREXQUANT INVESTMENT LP 05/14/2025 630.35 K $5.28 M   36.23% 0.20%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 624.70 K $5.23 M   -9.00% 0.20%
BANK OF NEW YORK MELLON CORP 04/29/2025 598.39 K $5.01 M   -4.08% 0.19%
RAYMOND JAMES FINANCIAL INC 05/13/2025 596.50 K $5.00 M   60.35% 0.19%
NUMERAI GP LLC 05/15/2025 596.13 K $5.00 M   100.00% 0.19%
ALGERT GLOBAL LLC 05/13/2025 560.78 K $4.70 M   25.74% 0.18%
WALLEYE CAPITAL LLC 05/14/2025 558.84 K $4.68 M   1,333.70% 0.18%
BANK OF AMERICA CORP /DE/ 05/15/2025 537.35 K $4.50 M   -3.51% 0.17%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/12/2025 527.69 K $4.42 M   -5.03% 0.17%
DARK FOREST CAPITAL MANAGEMENT LP 05/15/2025 499.71 K $4.19 M   3,256.22% 0.16%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 483.80 K $4.03 M   81.93% 0.16%
SEGALL BRYANT & HAMILL, LLC 05/02/2025 459.44 K $3.85 M   -2.32% 0.15%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 446.00 K $3.74 M   100.00% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 436.80 K $3.66 M   169.11% 0.14%
FIRST TRUST ADVISORS LP 05/14/2025 400.29 K $3.35 M   -40.47% 0.13%
MARINER, LLC 05/15/2025 393.52 K $3.30 M   -7.25% 0.13%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 360.83 K $3.02 M   70.90% 0.12%
SEI INVESTMENTS CO 05/14/2025 357.91 K $3.00 M   5.43% 0.12%

Amneal Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 268 institutional investors and hedge funds held shares of Amneal Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 15.76 M

BlackRock, Inc.: 12.59 M

TPG GP A, LLC: 12.33 M

Rubric Capital Management LP: 10.74 M

CITADEL ADVISORS LLC: 7.49 M

DIMENSIONAL FUND ADVISORS LP: 5.1 M

43.22% of Amneal Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 165.67 M shares in the last 24 months. This purchase volume represents approximately $1.28 B in transactions.